Insider · CIK 0001658080

Francois Cedric

CIK 0001658080 Name as filed on the most recent filing

Filed as Francois Cedric (39)

64 transaction lines · from 39 filings · filed 2019-08-16 to 2026-01-23 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

64 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-01-22 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 591,845, disposed Open Form 4 filing 0001492422-26-000057
2026-01-20 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 161,946, disposed Open Form 4 filing 0001492422-26-000041
2026-01-13 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 225,999, disposed Open Form 4 filing 0001492422-26-000028
2025-08-28 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 1,418,450, disposed Open Form 4 filing 0001193125-25-192797
2025-08-27 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 4,934,293, disposed Open Form 4 filing 0001193125-25-192797
2025-07-17 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 398,735, disposed Open Form 4 filing 0001127602-25-019413
2025-07-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 38,168, disposed Open Form 4 filing 0001127602-25-019265
2025-07-14 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 2,774,923, disposed Open Form 4 filing 0001127602-25-019265
2025-01-29 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 83,375, disposed Open Form 4 filing 0001127602-25-002375
2025-01-22 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 412,296, disposed Open Form 4 filing 0001127602-25-001837
2025-01-17 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 179,959, disposed Open Form 4 filing 0001127602-25-001620
2025-01-13 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 179,302, disposed Open Form 4 filing 0001127602-25-001197
2024-03-01 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 5 lines 16,028,706, disposed Open Form 4 filing 0001127602-24-008505
2024-02-12 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 268,492, disposed Open Form 4 filing 0001127602-24-004718
2024-01-29 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 182,345, disposed Open Form 4 filing 0001127602-24-002740
2024-01-22 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 872,961, disposed Open Form 4 filing 0001127602-24-001970
2024-01-16 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 524,514, disposed Open Form 4 filing 0001127602-24-001431
2023-11-21 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 244,000, disposed Open Form 4 filing 0000950170-23-065613
2023-09-01 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 2 lines 6,262,959, disposed Open Form 4 filing 0001127602-23-023560
2023-05-16 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 6 lines 2,569,900, disposed Open Form 4 filing 0001127602-23-016189
2023-04-18 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 2,460,720, disposed Open Form 4 filing 0001127602-23-013309
2023-03-21 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 1,882,332, disposed Open Form 4 filing 0001127602-23-011206
2022-12-19 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 2 lines 1,467,983, disposed Open Form 4 filing 0001127602-22-028072
2020-12-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 260,800, disposed Open Form 4 filing 0001127602-20-031562
2020-11-16 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 196,900, disposed Open Form 4 filing 0001127602-20-029369
2020-10-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 172,300, disposed Open Form 4 filing 0001127602-20-027098
2020-09-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 154,800, disposed Open Form 4 filing 0001127602-20-025183
2020-08-20 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 103,710, disposed Open Form 4 filing 0001127602-20-024043
2020-08-18 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 46,290, disposed Open Form 4 filing 0001127602-20-023992
2020-07-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 160,600, disposed Open Form 4 filing 0001127602-20-021646
2020-06-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 151,050, disposed Open Form 4 filing 0001127602-20-019731
2020-05-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 149,600, disposed Open Form 4 filing 0001127602-20-017181
2020-04-15 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 148,850, disposed Open Form 4 filing 0001127602-20-014100
2020-03-16 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 325,088, disposed Open Form 4 filing 0001127602-20-011263
2020-03-16 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 249,558, disposed Open Form 4 filing 0001127602-20-011263
2020-03-16 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 71,557, disposed Open Form 4 filing 0001127602-20-011263
2020-03-16 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 47,279, disposed Open Form 4 filing 0001127602-20-011263
2020-03-16 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 43,695, disposed Open Form 4 filing 0001127602-20-011263
2020-03-16 S, Open-market sale Apellis Pharmaceuticals, Inc.APLS 15,600, disposed Open Form 4 filing 0001127602-20-011263

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 64
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Francois Cedric, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001658080

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.